Finance

Lists
HRTX:NASDAQ
Heron Therapeutics Inc
$0.32
+2.98%
(+0.0092) 1D
$0.32
+0.57% (+0.0018)
After hours
Closed: Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRTX...
Open
$0.31
High
$0.33
Low
$0.31
Mkt. cap
60.22M
Avg. vol.
2.91M
Volume
3.02M
52-wk high
$1.58
52-wk low
$0.30
EPS
-$0.19
Beta
1.65
Shares outstanding
189.85M
No. of employees
128
Open
$0.31
High
$0.33
Low
$0.31
Mkt. cap
60.22M
Avg. vol.
2.91M
Volume
3.02M
52-wk high
$1.58
52-wk low
$0.30
EPS
-$0.19
Beta
1.65
Shares outstanding
189.85M
No. of employees
128
News stories
From web sources and news partners
About Heron Therapeutics Inc
CEO-
Employees128
Founded1983
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteherontx.com
Analyst ratings
Based on 2 analysts giving stock ratings to HRTX in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HRTX in the last 3 months.
Highest
Current $0.32
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Hold
Downgraded
-
-
08/17/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/10/2026
Carl Byrnes
Northland Securities
Buy
Reiterated
$4.00
+1,157.1%
11/05/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
38.21M
40.59M
34.71M
37.67M
Cost of goods sold
15.38M
14.86M
13.02M
14.27M
Cost of revenue
15.38M
14.86M
13.02M
14.27M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.92M
25.68M
26.45M
25.44M
Operating expense
26.92M
25.68M
26.45M
25.44M
Total operating expenses
42.31M
40.55M
39.48M
39.71M
Operating income
-4.09M
38.00K
-4.76M
-2.04M
Other non operating income
837.00K
-821.00K
-146.00K
355.00K
EBT including unusual items
-17.50M
-2.95M
-8.11M
-5.49M
EBT excluding unusual items
-6.16M
-2.54M
-8.11M
-5.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.50M
-2.95M
-8.11M
-5.49M
Net profit margin
-45.78%
-7.28%
-23.37%
-14.57%
Earnings per share
-0.04
-0.02
-0.04
-0.03
Interest and investment income
-
1.95M
-
-
Interest expense
-2.90M
-3.70M
-3.20M
-3.80M
Net interest expenses
-2.90M
-1.76M
-3.20M
-3.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.48M
575.00K
-4.24M
-1.59M
Gain or loss from assets sale
-95.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps